Ipamorelin's structure emerged from a different optimization strategyremoval of the central dipeptide from GHRP-1 combined with Aib N-terminal substitutionresulting in a pentapeptide with potency comparable to hexapeptide GHRPs but with fundamentally different selectivity
Some formulations also carry indications for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Buglio AL, Bellanti F, Carmignano DFP, et al
Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
In a recent clinical trial, CagriSema led to significant weight loss and reductions in A1C, with participants experiencing gastrointestinal side effects associated with GLP-1s
Geier DA, Kern JK, Geier MR (2009) A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders